CAS: 1429321-13-0
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | (2E)-2-[1-[5-(4-Bromophenyl)-4-hydroxy-3-thienyl]ethylidene]hydrazide-5-[[[[4-[[(2-hydroxyethyl)amino]carbonyl]phenyl]methyl]amino]carbonyl]-2-thiophenecarboxylic Acid REF: TR-B701335CAS: 1429321-13-0 | - - - | 22.640,00 € | Sex 24 Jan 25 |
 | TA-316 REF: TM-T13769CAS: 1429321-13-0 | 98% | 651,00 €~3.726,00 € | Seg 17 Mar 25 |
![(2E)-2-[1-[5-(4-Bromophenyl)-4-hydroxy-3-thienyl]ethylidene]hydrazide-5-[[[[4-[[(2-hydroxyethyl)am…](https://static.cymitquimica.com/products/TR/thumb/B701335.jpg)
(2E)-2-[1-[5-(4-Bromophenyl)-4-hydroxy-3-thienyl]ethylidene]hydrazide-5-[[[[4-[[(2-hydroxyethyl)amino]carbonyl]phenyl]methyl]amino]carbonyl]-2-thiophenecarboxylic Acid
Produto ControladoCAS:1429321-13-0
Fórmula:
C28H25BrN4O5S2
Cor e Forma:
Neat
Peso molecular:
641.556
Ref: TR-B701335
| 100mg | 22.640,00 € |
Entrega estimada em Estados Unidos, Sexta-feira 24 de Janeiro de 2025
TA-316
CAS:1429321-13-0
Agent induces megakaryocytes/platelets from stem cells to treat thrombopenia.
Fórmula:
C28H25BrN4O5S2
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
641.56
Ref: TM-T13769
| 25mg | 2.106,00 € | ||
| 50mg | 2.776,00 € | ||
| 100mg | 3.726,00 € |
Entrega estimada em Estados Unidos, Segunda-feira 17 de Março de 2025
